Dopamine, immunity, and disease

B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - ASPET
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …

[HTML][HTML] Translational molecular imaging and drug development in Parkinson's disease

A Haider, NH Elghazawy, A Dawoud… - Molecular …, 2023 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects
elderly people and constitutes a major source of disability worldwide. Notably, the …

Dopamine receptors in Parkinson's disease: a meta‐analysis of imaging studies

V Kaasinen, T Vahlberg, AJ Stoessl… - Movement …, 2021 - Wiley Online Library
Dopamine receptors are abundant along the central nigrostriatal tract and are expressed as
5 subtypes in two receptor families. In PD, compensatory changes in dopamine receptors …

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

DS Goldstein, IJ Kopin, Y Sharabi - Pharmacology & therapeutics, 2014 - Elsevier
Several neurodegenerative diseases involve loss of catecholamine neurons—Parkinson
disease is a prototypical example. Catecholamine neurons are rare in the nervous system …

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

M Ghaemi, R Hilker, J Rudolf, J Sobesky… - Journal of Neurology …, 2002 - jnnp.bmj.com
Objectives: The differential diagnosis between typical idiopathic Parkinson's disease (PD)
and the striatonigral variant of multiple system atrophy (MSA-P) is often difficult because of …

Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing

MR Drew, EH Simpson, C Kellendonk… - Journal of …, 2007 - Soc Neuroscience
The striatum receives prominent dopaminergic innervation that is integral to appetitive
learning, performance, and motivation. Signaling through the dopamine D2 receptor is …

[HTML][HTML] Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease

P Riederer, T Nagatsu, MBH Youdim, M Wulf… - Journal of Neural …, 2023 - Springer
Since the description of some peculiar symptoms by James Parkinson in 1817, attempts
have been made to define its cause or at least to enlighten the pathology of “Parkinson's …

Functional reorganization of sensorimotor cortex in early Parkinson disease

M Kojovic, M Bologna, P Kassavetis, N Murase… - Neurology, 2012 - AAN Enterprises
Objective: Compensatory reorganization of the nigrostriatal system is thought to delay the
onset of symptoms in early Parkinson disease (PD). Here we sought evidence that …

Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease

D Geng, YX Li, CS Zee - Neurosurgery, 2006 - journals.lww.com
OBJECTIVE: Parkinson's disease (PD) is associated with well-documented morphological
changes in substantia nigra and basal ganglia nuclei. This study evaluates the ability of …

Understanding decision-making deficits in neurological conditions: insights from models of natural action selection

MJ Frank, A Scheres… - … Transactions of the …, 2007 - royalsocietypublishing.org
Models of natural action selection implicate fronto-striatal circuits in both motor and cognitive
'actions'. Dysfunction of these circuits leads to decision-making deficits in various …